Global Drugs for Vulvovaginal Candidiasis Market Growth 2021-2026

Publisher Name :
Date: 16-Jul-2021
No. of pages: 101

According to this latest study, the 2021 growth of Drugs for Vulvovaginal Candidiasis will have significant change from previous year. By the most conservative estimates of global Drugs for Vulvovaginal Candidiasis market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 787 million in 2020. Over the next five years the Drugs for Vulvovaginal Candidiasis market will register a 1.6% CAGR in terms of revenue, the global market size will reach US$ 837.1 million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Vulvovaginal Candidiasis market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

- Cream

- Pessary

- Other

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

- Hospital & Clinic

- Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

- Bayer

- Perrigo

- J & J

- Pfizer

- Bristol-Myers Squibb

- Effik

- Teva

- Sanofi

- Cisen Pharmaceutical

- Kingyork Group

Global Drugs for Vulvovaginal Candidiasis Market Growth 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for Vulvovaginal Candidiasis Consumption 2016-2026
2.1.2 Drugs for Vulvovaginal Candidiasis Consumption CAGR by Region
2.2 Drugs for Vulvovaginal Candidiasis Segment by Type
2.2.1 Cream
2.2.2 Pessary
2.2.3 Other
2.3 Drugs for Vulvovaginal Candidiasis Sales by Type
2.3.1 Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2016-2021)
2.3.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Type (2016-2021)
2.3.3 Global Drugs for Vulvovaginal Candidiasis Sale Price by Type (2016-2021)
2.4 Drugs for Vulvovaginal Candidiasis Segment by Application
2.4.1 Hospital & Clinic
2.4.2 Pharmacy
2.5 Drugs for Vulvovaginal Candidiasis Sales by Application
2.5.1 Global Drugs for Vulvovaginal Candidiasis Sale Market Share by Application (2016-2021)
2.5.2 Global Drugs for Vulvovaginal Candidiasis Revenue and Market Share by Application (2016-2021)
2.5.3 Global Drugs for Vulvovaginal Candidiasis Sale Price by Application (2016-2021)

3 Global Drugs for Vulvovaginal Candidiasis by Company
3.1 Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Company
3.1.1 Global Drugs for Vulvovaginal Candidiasis Sales by Company (2019-2021)
3.1.2 Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Company (2019-2021)
3.2 Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Company
3.2.1 Global Drugs for Vulvovaginal Candidiasis Revenue by Company (2019-2021)
3.2.2 Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Company (2019-2021)
3.3 Global Drugs for Vulvovaginal Candidiasis Sale Price by Company
3.4 Global Manufacturers Drugs for Vulvovaginal Candidiasis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drugs for Vulvovaginal Candidiasis Product Location Distribution
3.4.2 Players Drugs for Vulvovaginal Candidiasis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Drugs for Vulvovaginal Candidiasis by Region
4.1 Global Drugs for Vulvovaginal Candidiasis by Region
4.1.1 Global Drugs for Vulvovaginal Candidiasis Sales by Region
4.1.2 Global Drugs for Vulvovaginal Candidiasis Revenue by Region
4.2 Americas Drugs for Vulvovaginal Candidiasis Sales Growth
4.3 APAC Drugs for Vulvovaginal Candidiasis Sales Growth
4.4 Europe Drugs for Vulvovaginal Candidiasis Sales Growth
4.5 Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales Growth

5 Americas
5.1 Americas Drugs for Vulvovaginal Candidiasis Sales by Country
5.1.1 Americas Drugs for Vulvovaginal Candidiasis Sales by Country (2016-2021)
5.1.2 Americas Drugs for Vulvovaginal Candidiasis Revenue by Country (2016-2021)
5.2 Americas Drugs for Vulvovaginal Candidiasis Sales by Type
5.3 Americas Drugs for Vulvovaginal Candidiasis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Drugs for Vulvovaginal Candidiasis Sales by Region
6.1.1 APAC Drugs for Vulvovaginal Candidiasis Sales by Region (2016-2021)
6.1.2 APAC Drugs for Vulvovaginal Candidiasis Revenue by Region (2016-2021)
6.2 APAC Drugs for Vulvovaginal Candidiasis Sales by Type
6.3 APAC Drugs for Vulvovaginal Candidiasis Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Drugs for Vulvovaginal Candidiasis by Country
7.1.1 Europe Drugs for Vulvovaginal Candidiasis Sales by Country (2016-2021)
7.1.2 Europe Drugs for Vulvovaginal Candidiasis Revenue by Country (2016-2021)
7.2 Europe Drugs for Vulvovaginal Candidiasis Sales by Type
7.3 Europe Drugs for Vulvovaginal Candidiasis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Drugs for Vulvovaginal Candidiasis by Country
8.1.1 Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales by Country (2016-2021)
8.1.2 Middle East & Africa Drugs for Vulvovaginal Candidiasis Revenue by Country (2016-2021)
8.2 Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales by Type
8.3 Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Drugs for Vulvovaginal Candidiasis Distributors
10.3 Drugs for Vulvovaginal Candidiasis Customer

11 Global Drugs for Vulvovaginal Candidiasis Market Forecast
11.1 Global Drugs for Vulvovaginal Candidiasis Forecast by Region
11.1.1 Global Drugs for Vulvovaginal Candidiasis Forecast by Regions (2021-2026)
11.2.2 Global Drugs for Vulvovaginal Candidiasis Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Drugs for Vulvovaginal Candidiasis Forecast by Type
11.7 Global Drugs for Vulvovaginal Candidiasis Forecast by Application

12 Key Players Analysis
12.1 Bayer
12.1.1 Bayer Company Information
12.1.2 Bayer Drugs for Vulvovaginal Candidiasis Product Offered
12.1.3 Bayer Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Bayer Main Business Overview
12.1.5 Bayer Latest Developments
12.2 Perrigo
12.2.1 Perrigo Company Information
12.2.2 Perrigo Drugs for Vulvovaginal Candidiasis Product Offered
12.2.3 Perrigo Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Perrigo Main Business Overview
12.2.5 Perrigo Latest Developments
12.3 J & J
12.3.1 J & J Company Information
12.3.2 J & J Drugs for Vulvovaginal Candidiasis Product Offered
12.3.3 J & J Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 J & J Main Business Overview
12.3.5 J & J Latest Developments
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer Drugs for Vulvovaginal Candidiasis Product Offered
12.4.3 Pfizer Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Pfizer Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Information
12.5.2 Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Product Offered
12.5.3 Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Bristol-Myers Squibb Main Business Overview
12.5.5 Bristol-Myers Squibb Latest Developments
12.6 Effik
12.6.1 Effik Company Information
12.6.2 Effik Drugs for Vulvovaginal Candidiasis Product Offered
12.6.3 Effik Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Effik Main Business Overview
12.6.5 Effik Latest Developments
12.7 Teva
12.7.1 Teva Company Information
12.7.2 Teva Drugs for Vulvovaginal Candidiasis Product Offered
12.7.3 Teva Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Teva Main Business Overview
12.7.5 Teva Latest Developments
12.8 Sanofi
12.8.1 Sanofi Company Information
12.8.2 Sanofi Drugs for Vulvovaginal Candidiasis Product Offered
12.8.3 Sanofi Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Sanofi Main Business Overview
12.8.5 Sanofi Latest Developments
12.9 Cisen Pharmaceutical
12.9.1 Cisen Pharmaceutical Company Information
12.9.2 Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Product Offered
12.9.3 Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Cisen Pharmaceutical Main Business Overview
12.9.5 Cisen Pharmaceutical Latest Developments
12.10 Kingyork Group
12.10.1 Kingyork Group Company Information
12.10.2 Kingyork Group Drugs for Vulvovaginal Candidiasis Product Offered
12.10.3 Kingyork Group Drugs for Vulvovaginal Candidiasis Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Kingyork Group Main Business Overview
12.10.5 Kingyork Group Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Drugs for Vulvovaginal Candidiasis Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Cream
Table 3. Major Players of Pessary
Table 4. Major Players of Other
Table 5. Global Drugs for Vulvovaginal Candidiasis Sales by Type (2016-2021) & (K Units)
Table 6. Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2016-2021)
Table 7. Global Drugs for Vulvovaginal Candidiasis Revenue by Type (2016-2021) & ($ million)
Table 8. Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Type (2016-2021)
Table 9. Global Drugs for Vulvovaginal Candidiasis Sale Price by Type (2016-2021)
Table 10. Global Drugs for Vulvovaginal Candidiasis Sales by Application (2016-2021) & (K Units)
Table 11. Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2016-2021)
Table 12. Global Drugs for Vulvovaginal Candidiasis Value by Application (2016-2021)
Table 13. Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Application (2016-2021)
Table 14. Global Drugs for Vulvovaginal Candidiasis Sale Price by Application (2016-2021)
Table 15. Global Drugs for Vulvovaginal Candidiasis Sales by Company (2019-2021) & (K Units)
Table 16. Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Company (2019-2021)
Table 17. Global Drugs for Vulvovaginal Candidiasis Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Company (2019-2021)
Table 19. Global Drugs for Vulvovaginal Candidiasis Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Drugs for Vulvovaginal Candidiasis Producing Area Distribution and Sales Area
Table 21. Players Drugs for Vulvovaginal Candidiasis Products Offered
Table 22. Drugs for Vulvovaginal Candidiasis Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Drugs for Vulvovaginal Candidiasis Sales by Region (2016-2021) (K Units)
Table 26. Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Region (2016-2021)
Table 27. Global Drugs for Vulvovaginal Candidiasis Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Region (2016-2021)
Table 29. Americas Drugs for Vulvovaginal Candidiasis Sales by Country (2016-2021) & (K Units)
Table 30. Americas Drugs for Vulvovaginal Candidiasis Sales Market Share by Country (2016-2021)
Table 31. Americas Drugs for Vulvovaginal Candidiasis Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Drugs for Vulvovaginal Candidiasis Revenue Market Share by Country (2016-2021)
Table 33. Americas Drugs for Vulvovaginal Candidiasis Sales by Type (2016-2021) & (K Units)
Table 34. Americas Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2016-2021)
Table 35. Americas Drugs for Vulvovaginal Candidiasis Sales by Application (2016-2021) & (K Units)
Table 36. Americas Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2016-2021)
Table 37. APAC Drugs for Vulvovaginal Candidiasis Sales by Region (2016-2021) & (K Units)
Table 38. APAC Drugs for Vulvovaginal Candidiasis Sales Market Share by Region (2016-2021)
Table 39. APAC Drugs for Vulvovaginal Candidiasis Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Drugs for Vulvovaginal Candidiasis Revenue Market Share by Region (2016-2021)
Table 41. APAC Drugs for Vulvovaginal Candidiasis Sales by Type (2016-2021) & (K Units)
Table 42. APAC Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2016-2021)
Table 43. APAC Drugs for Vulvovaginal Candidiasis Sales by Application (2016-2021) & (K Units)
Table 44. APAC Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2016-2021)
Table 45. Europe Drugs for Vulvovaginal Candidiasis Sales by Country (2016-2021) & (K Units)
Table 46. Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Country (2016-2021)
Table 47. Europe Drugs for Vulvovaginal Candidiasis Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Drugs for Vulvovaginal Candidiasis Revenue Market Share by Country (2016-2021)
Table 49. Europe Drugs for Vulvovaginal Candidiasis Sales by Type (2016-2021) & (K Units)
Table 50. Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2016-2021)
Table 51. Europe Drugs for Vulvovaginal Candidiasis Sales by Application (2016-2021) & (K Units)
Table 52. Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Drugs for Vulvovaginal Candidiasis Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Drugs for Vulvovaginal Candidiasis Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of Drugs for Vulvovaginal Candidiasis
Table 62. Key Application and Potential Industries of Drugs for Vulvovaginal Candidiasis
Table 63. Key Challenges of Drugs for Vulvovaginal Candidiasis
Table 64. Key Trends of Drugs for Vulvovaginal Candidiasis
Table 65. Drugs for Vulvovaginal Candidiasis Distributors List
Table 66. Drugs for Vulvovaginal Candidiasis Customer List
Table 67. Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Region (2021-2026) & (K Units)
Table 68. Global Drugs for Vulvovaginal Candidiasis Consumption Market Forecast by Region
Table 69. Global Drugs for Vulvovaginal Candidiasis Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global Drugs for Vulvovaginal Candidiasis Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas Drugs for Vulvovaginal Candidiasis Sales Forecast by Country (2021-2026) & (K Units)
Table 72. Americas Drugs for Vulvovaginal Candidiasis Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC Drugs for Vulvovaginal Candidiasis Sales Forecast by Region (2021-2026) & (K Units)
Table 74. APAC Drugs for Vulvovaginal Candidiasis Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe Drugs for Vulvovaginal Candidiasis Sales Forecast by Country (2021-2026) & (K Units)
Table 76. Europe Drugs for Vulvovaginal Candidiasis Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales Forecast by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Drugs for Vulvovaginal Candidiasis Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Type (2021-2026) & (K Units)
Table 80. Global Drugs for Vulvovaginal Candidiasis Sales Market Share Forecast by Type (2021-2026)
Table 81. Global Drugs for Vulvovaginal Candidiasis Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global Drugs for Vulvovaginal Candidiasis Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global Drugs for Vulvovaginal Candidiasis Sales Forecast by Application (2021-2026) & (K Units)
Table 84. Global Drugs for Vulvovaginal Candidiasis Sales Market Share Forecast by Application (2021-2026)
Table 85. Global Drugs for Vulvovaginal Candidiasis Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global Drugs for Vulvovaginal Candidiasis Revenue Market Share Forecast by Application (2021-2026)
Table 87. Bayer Basic Information, Drugs for Vulvovaginal Candidiasis Manufacturing Base, Sales Area and Its Competitors
Table 88. Bayer Drugs for Vulvovaginal Candidiasis Product Offered
Table 89. Bayer Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 90. Bayer Main Business
Table 91. Bayer Latest Developments
Table 92. Perrigo Basic Information, Drugs for Vulvovaginal Candidiasis Manufacturing Base, Sales Area and Its Competitors
Table 93. Perrigo Drugs for Vulvovaginal Candidiasis Product Offered
Table 94. Perrigo Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 95. Perrigo Main Business
Table 96. Perrigo Latest Developments
Table 97. J & J Basic Information, Drugs for Vulvovaginal Candidiasis Manufacturing Base, Sales Area and Its Competitors
Table 98. J & J Drugs for Vulvovaginal Candidiasis Product Offered
Table 99. J & J Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 100. J & J Main Business
Table 101. J & J Latest Developments
Table 102. Pfizer Basic Information, Drugs for Vulvovaginal Candidiasis Manufacturing Base, Sales Area and Its Competitors
Table 103. Pfizer Drugs for Vulvovaginal Candidiasis Product Offered
Table 104. Pfizer Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 105. Pfizer Main Business
Table 106. Pfizer Latest Developments
Table 107. Bristol-Myers Squibb Basic Information, Drugs for Vulvovaginal Candidiasis Manufacturing Base, Sales Area and Its Competitors
Table 108. Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Product Offered
Table 109. Bristol-Myers Squibb Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 110. Bristol-Myers Squibb Main Business
Table 111. Bristol-Myers Squibb Latest Developments
Table 112. Effik Basic Information, Drugs for Vulvovaginal Candidiasis Manufacturing Base, Sales Area and Its Competitors
Table 113. Effik Drugs for Vulvovaginal Candidiasis Product Offered
Table 114. Effik Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 115. Effik Main Business
Table 116. Effik Latest Developments
Table 117. Teva Basic Information, Drugs for Vulvovaginal Candidiasis Manufacturing Base, Sales Area and Its Competitors
Table 118. Teva Drugs for Vulvovaginal Candidiasis Product Offered
Table 119. Teva Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 120. Teva Main Business
Table 121. Teva Latest Developments
Table 122. Sanofi Basic Information, Drugs for Vulvovaginal Candidiasis Manufacturing Base, Sales Area and Its Competitors
Table 123. Sanofi Drugs for Vulvovaginal Candidiasis Product Offered
Table 124. Sanofi Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 125. Sanofi Main Business
Table 126. Sanofi Latest Developments
Table 127. Cisen Pharmaceutical Basic Information, Drugs for Vulvovaginal Candidiasis Manufacturing Base, Sales Area and Its Competitors
Table 128. Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Product Offered
Table 129. Cisen Pharmaceutical Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 130. Cisen Pharmaceutical Main Business
Table 131. Cisen Pharmaceutical Latest Developments
Table 132. Kingyork Group Basic Information, Drugs for Vulvovaginal Candidiasis Manufacturing Base, Sales Area and Its Competitors
Table 133. Kingyork Group Drugs for Vulvovaginal Candidiasis Product Offered
Table 134. Kingyork Group Drugs for Vulvovaginal Candidiasis Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 135. Kingyork Group Main Business
Table 136. Kingyork Group Latest Developments
List of Figures
Figure 1. Picture of Drugs for Vulvovaginal Candidiasis
Figure 2. Drugs for Vulvovaginal Candidiasis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drugs for Vulvovaginal Candidiasis Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Drugs for Vulvovaginal Candidiasis Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Drugs for Vulvovaginal Candidiasis Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Cream
Figure 10. Product Picture of Pessary
Figure 11. Product Picture of Other
Figure 12. Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Type in 2020
Figure 13. Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Type (2016-2021)
Figure 14. Drugs for Vulvovaginal Candidiasis Consumed in Hospital & Clinic
Figure 15. Global Drugs for Vulvovaginal Candidiasis Market: Hospital & Clinic (2016-2021) & (K Units)
Figure 16. Drugs for Vulvovaginal Candidiasis Consumed in Pharmacy
Figure 17. Global Drugs for Vulvovaginal Candidiasis Market: Pharmacy (2016-2021) & (K Units)
Figure 18. Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Application (2016-2021)
Figure 19. Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Application in 2020
Figure 20. Drugs for Vulvovaginal Candidiasis Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Company in 2020
Figure 22. Global Drugs for Vulvovaginal Candidiasis Sales Market Share by Regions (2016-2021)
Figure 23. Global Drugs for Vulvovaginal Candidiasis Revenue Market Share by Region in 2020
Figure 24. Americas Drugs for Vulvovaginal Candidiasis Sales 2016-2021 (K Units)
Figure 25. Americas Drugs for Vulvovaginal Candidiasis Revenue 2016-2021 ($ Millions)
Figure 26. APAC Drugs for Vulvovaginal Candidiasis Sales 2016-2021 (K Units)
Figure 27. APAC Drugs for Vulvovaginal Candidiasis Revenue 2016-2021 ($ Millions)
Figure 28. Europe Drugs for Vulvovaginal Candidiasis Sales 2016-2021 (K Units)
Figure 29. Europe Drugs for Vulvovaginal Candidiasis Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales 2016-2021 (K Units)
Figure 31. Middle East & Africa Drugs for Vulvovaginal Candidiasis Revenue 2016-2021 ($ Millions)
Figure 32. Americas Drugs for Vulvovaginal Candidiasis Sales Market Share by Country in 2020
Figure 33. Americas Drugs for Vulvovaginal Candidiasis Revenue Market Share by Country in 2020
Figure 34. Americas Drugs for Vulvovaginal Candidiasis Sales Market Share by Type in 2020
Figure 35. Americas Drugs for Vulvovaginal Candidiasis Sales Market Share by Application in 2020
Figure 36. United States Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Drugs for Vulvovaginal Candidiasis Sales Market Share by Region in 2020
Figure 41. APAC Drugs for Vulvovaginal Candidiasis Revenue Market Share by Regions in 2020
Figure 42. APAC Drugs for Vulvovaginal Candidiasis Sales Market Share by Type in 2020
Figure 43. APAC Drugs for Vulvovaginal Candidiasis Sales Market Share by Application in 2020
Figure 44. China Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Country in 2020
Figure 51. Europe Drugs for Vulvovaginal Candidiasis Revenue Market Share by Country in 2020
Figure 52. Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Type in 2020
Figure 53. Europe Drugs for Vulvovaginal Candidiasis Sales Market Share by Application in 2020
Figure 54. Germany Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Drugs for Vulvovaginal Candidiasis Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Drugs for Vulvovaginal Candidiasis Sales Market Share by Application in 2020
Figure 63. Egypt Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Drugs for Vulvovaginal Candidiasis Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
  • United States Contraceptives Market Report & Forecast 2021-2027
    Published: 13-Sep-2021        Price: US 3400 Onwards        Pages: 93
    United States Contraceptives Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT) United States Contraceptives Market Segment Percentages, By Type, 2020 (%) - Prolonged Contraception - Short-term Contraception - Emergency Contraception United States Contraceptives Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT) United States Contraceptives Market Segment Percentages, By Application, 2020 (%) - Hospital Pharmacies......
  • Global and Japan Bacterial Vaginosis Drug Market Size, Status and Forecast 2021-2027
    Published: 10-Sep-2021        Price: US 3900 Onwards        Pages: 124
    This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs. Global Bacterial Vaginosis Drug key players include Bayer, Pfizer, Sanofi, Piramal, Abbott, etc. Global top five manufacturers hold a share about 20%. North America a......
  • Global and United States Contraceptives Market Insights, Forecast to 2027
    Published: 10-Sep-2021        Price: US 3900 Onwards        Pages: 148
    Contraceptives are a kind of medicine used to prevent unwanted pregnancy. It consists of one or more synthetic female sex hormones. These sex hormones prevent pregnancy by blocking the normal process of ovulation. Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share. The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Ged......
  • United States Drugs for Vulvovaginal Candidiasis Market Report & Forecast 2021-2027
    Published: 10-Sep-2021        Price: US 3400 Onwards        Pages: 90
    United States Drugs for Vulvovaginal Candidiasis Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Drugs for Vulvovaginal Candidiasis Market Segment Percentages, By Type, 2020 (%) - Cream - Pessary - Other United States Drugs for Vulvovaginal Candidiasis Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) United States Drugs for Vulvovaginal Candidiasis Market Segment Percentages, By Application, 2020 ......
  • United States Bacterial Vaginosis Drug Market Report & Forecast 2021-2027
    Published: 08-Sep-2021        Price: US 3400 Onwards        Pages: 109
    United States Bacterial Vaginosis Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) United States Bacterial Vaginosis Drug Market Segment Percentages, By Type, 2020 (%) - Rx - OTC United States Bacterial Vaginosis Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) United States Bacterial Vaginosis Drug Market Segment Percentages, By Application, 2020 (%) - Hospital - Pharmacy - Other Competitor Analy......
  • 2021-2030 Report on Global Bacterial Vaginosis Drug Market by Player, Region, Type, Application and Sales Channel
    Published: 07-Sep-2021        Price: US 2500 Onwards        Pages: 117
    This report studies the Bacterial Vaginosis Drug market, covering market size for segment by type (Rx Drugs, OTC Drugs, etc.), by application (Hospitals & Clinics, Retail Pharmacy, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Bayer, Pfizer, Sanofi, Piramal, Abbott, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Bacterial Vaginosis......
  • Global and United States Oral Contraceptive Market Insights, Forecast to 2027
    Published: 31-Aug-2021        Price: US 3900 Onwards        Pages: 139
    Oral Contraceptive market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Oral Contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For United States market, this report focuses on the Oral Contra......
  • Global Bacterial Vaginosis Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 27-Aug-2021        Price: US 3480 Onwards        Pages: 138
    The Bacterial Vaginosis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our lates......
  • Global Contraceptives Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 26-Aug-2021        Price: US 3480 Onwards        Pages: 107
    The Contraceptives market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest research......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs